Martínez Montoro, José IgnacioPinazo Bandera, José M.García Serrano, SaraGarcía Almeida, José ManuelOcaña Wilhelmi, LuisMoreno Ruiz, Francisco JavierSoler Humanes, RocíoRuiz Campos, NereaSancho Marín, RaquelGarcía Cortés, MirenEt. al.2026-09-252026-09-252026Martínez-Montoro, J. I., Pinazo-Bandera, J. M., García-Serrano, S., García-Almeida, J. M., Ocaña-Wilhelmi, L., Moreno-Ruiz, F. J., Soler-Humanes, R., Ruiz-Campos, N., Sancho-Marín, R., García-Cortés, M., Muñoz-Garach, A., Fernández-García, J. C., García-Fuentes, E., Tinahones, F. J., & Garrido-Sánchez, L. (2026). Baseline Hepamet fibrosis score is associated with type 2 diabetes remission after bariatric surgery. Surgery for Obesity and Related Diseases, 22(10), 1140-1147. https://doi.org/10.1016/j.soard.2026.05.0161550-72891878-7533https://hdl.handle.net/11268/17441Type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) share common pathophysiological mechanisms and exert reciprocal influences on each other. Bariatric surgery (BS) is the most effective treatment for the improvement and resolution of both conditions; however, little is known about the role of MASLD in diabetes remission following BS.engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/OdontologíaCirugía BariátricaDiabetes Mellitus Tipo 2Enfermedad del Hígado Graso no Alcohólicojournal article10.1016/j.soard.2026.05.016open accessSistema endocrinoEnfermedadCirugíaGoal 3: Ensure healthy lives and promote well-being for all at all ages